**Abstract**

NMDA receptor (NMDAR) hypofunction in parvalbumin-positive inhibitory interneurons (PV-IN) may underlie the pathogenesis of psychiatric diseases such as autism and schizophrenia by excitation-inhibition (E/I) imbalance. However, cellular mechanism of cognitive dysfunction by NMDAR hypofunction in PV-IN is still unclear. It remains uncertain how chronic NMDAR hypofunction in PV-IN leads to E/I imbalance at basal as well as evoked synaptic strength. Here, we applied not only *in vitro* system with primary cortical culture pre-treated with the NMDAR antagonist, mk-801 but also *in vivo* mouse model with systemically repeated injection of mk-801 showing several cognitive dysfunctions including hyperlocomotion, impaired working memory, social deficit, and disrupted paired-pulse inhibition (PPI). In *in vitro* primary cortical culture system and medial prefrontal cortex (mPFC) in our *in vivo* mouse model, chronic NMDAR hypofunction in PV-INs induced AMPA receptor (AMPAR) downregulation, while NMDAR and AMPAR in pyramidal neurons (PY) were not affected. Moreover, alteration of synaptic strength in PV-IN is highly correlated with mPFC dependent cognitive function, working memory. The reduced synaptic strength of PV-IN caused disinhibition onto PY and increased E/I ratio, resulting in hyper-excitation in mPFC. This also disturbed synaptic plasticity of PY in mPFC. Reduced AMPAR strength in PV-IN was recovered by microinjection of PKA activator, forskolin into mPFC, giving rise to improved working memory and PPI. Together, these results indicate that chronic NMDAR hypofunction in PV-IN is associated with downregulation of AMPAR through PKA inactivation, which leads to E/I imbalance in mPFC by disinhibition onto PY, conferring psychiatric symptoms.
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